MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19

MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufacturers -- Cipla, Dr Reddy's Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical Industries, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aKMoUG
via IFTTT